Últimos Artículos de Metabolism Clinical and Experimental
- ApoC2 deficiency elicits severe hypertriglyceridemia and spontaneous atherosclerosis: a rodent model rescued from neonatal death
- Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors
- A multi-omic analysis of birthweight in newborn cord blood reveals new underlying mechanisms related to cholesterol metabolism
- The efficacy and safety of Dipeptyl Peptidase-4 inhibitors compared to other Oral glucose-lowering medications in the treatment of type 2 diabetes
- Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease
- Mof regulates glucose level via altering different α-cell subset mass and intra-islet glucagon-like peptide-1, glucagon secretion
- Editorial Board
- Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
- Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance
- Non-specific effects resulting from use of tocilizumab in mice
- GATA3 induces the upregulation of UCP-1 by directly binding to PGC-1α during adipose tissue browning
- Glucose control: not just a bystander in GLP-1RA-mediated cardiovascular protection
- Myths and Facts on Vitamin D Amidst the COVID-19 Pandemic
- Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
- “Extra-skeletal effects of bisphosphonates”
- Multi-Year Reproducibility of Hyperinsulinemic Euglycemic Clamp-Derived Insulin Sensitivity in Free-Living Adults: Association with Incident Prediabetes in the POP-ABC Study
- Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York
- FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes.
- Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
- Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next